MedTrace Logo

Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress Syndrome

NCT06250348 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-03-30

No results posted yet for this study

Summary

The aim of the study is to see if endogenous exhaled Nitric Oxyde (eNO) concentrations measured are significantly higher in ARDS patients admitted in ICU ; compared to control subjects in good health with no lung disease or global inflammation, operated under general anesthesia (i.e. intubated and ventilated) for thyroid or parathyroid.

Conditions

  • ARDS, Human
  • Nitric Oxyde

Interventions

OTHER

Non invasive measure of endogenous exhaled Nitric Oxyde in exhaled gaz, by a laser spectrometer

A sample of exhaled gases is taken from the expiratory part of the respirator circuit (same way as a capnometry measurement). A laser spectrometer continuously and non-invasively monitors online the concentrations of endogenous NO exhaled by patients.

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Raphael BRIOT, MD ; PhD · Laboratoire TIMC - Team PRETA UMR CNRS-UGA 5525 ; Grenoble Alpes University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2024-09-01
Completion
2025-01-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06250348 on ClinicalTrials.gov